Dynavax Technologies reported $16.07M in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Adma Biologics ADMA:US $ -14.44M 1.14M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Amgen AMGN:US $ 2378M 1550M
Astrazeneca AZN:US -1674000000 2.8B
AstraZeneca AZN:LN -1674000000 2.8B
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bristol Myers Squibb BMY:US $ 1996M 281M
Chimerix CMRX:US -18600000 785K
Dynavax Technologies DVAX:US $ 16.07M 12.13M
Gilead Sciences GILD:US $ 3842M 1596M
Glaxosmithkline GSK:US $ 1938M 263M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Idera Pharmaceuticals IDRA:US $ -5.97M 1.59M
Merk MRK:US $ 4826M 3212M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Tg Therapeutics TGTX:US $ -85.13M 7.64M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M